Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
James E. Brownell(AstraZeneca (United States)), Lawrence R. Dick(Millennium Engineering and Integration (United States)), William D. Mallender(Millennium Engineering and Integration (United States)), Dongyun Wu(Millennium Engineering and Integration (United States)), Todd B. Sells(Millennium Engineering and Integration (United States)), Michael D. Sintchak(Millennium Engineering and Integration (United States)), Štěpán Vyskočil(Scripps Research Institute), Irache Visiers(Millennium Engineering and Integration (United States)), Jingya Ma(Millennium Engineering and Integration (United States)), Joseph B. Bolen(Bristol-Myers Squibb (United States)), Huay-Keng Loke(Millennium Engineering and Integration (United States)), Trupti Lingaraj, Mark Rolfe(Unknown), Michael A. Milhollen(Millennium Engineering and Integration (United States)), Teresa A. Soucy(Millennium Engineering and Integration (United States)), James J. Spelman(Millennium Engineering and Integration (United States)), Hua Liao(Millennium Engineering and Integration (United States)), Steven Langston(Millennium Engineering and Integration (United States)), James M. Gavin(Millennium Engineering and Integration (United States)), Courtney Cullis(Millennium Engineering and Integration (United States)), Frank J. Bruzzese(Millennium Engineering and Integration (United States)), Ping Li(Henan Academy of Agricultural Sciences), Xiaofeng Yang(Millennium Engineering and Integration (United States)), Nancy J. Bump(Millennium Engineering and Integration (United States)), Kristin B. Hamman(Millennium Engineering and Integration (United States)), Anne L. Burkhardt(Millennium Engineering and Integration (United States)), Christopher F. Claiborne(Roche (Switzerland))
Cited by 461
Related Papers
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
|Nature Reviews Drug Discovery|2010|554
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
|Proceedings of the National Academy of Sciences|2007|413